Cargando…

The impact of thyroid hormones on patients with hepatocellular carcinoma

BACKGROUND & AIMS: Hypothyroidism has recently been proposed as predisposing factor for HCC development. However, the role of thyroid hormones (TH) in established HCC is largely unclear. We investigated the impact of TH on clinical characteristics and prognosis of HCC patients. METHODS: Of 838 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinter, Matthias, Haupt, Lukas, Hucke, Florian, Bota, Simona, Bucsics, Theresa, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542594/ https://www.ncbi.nlm.nih.gov/pubmed/28771610 http://dx.doi.org/10.1371/journal.pone.0181878

Ejemplares similares

Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience
por: Peck-Radosavljevic, Markus, et al.
Publicado: (2020)

Changing Epidemiological Trends of Hepatobiliary Carcinomas in Austria 2010–2018
por: Hucke, Florian, et al.
Publicado: (2022)

Changes in the Epidemiology of Hepatocellular Carcinoma in Carinthia, Austria, 2012–2023
por: Hucke, Florian, et al.
Publicado: (2023)

Cancer and liver cirrhosis: implications on prognosis and management
por: Pinter, Matthias, et al.
Publicado: (2016)

Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites
por: Mandorfer, Mattias, et al.
Publicado: (2014)

Review article: systemic treatment of hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2018)

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
por: Pinter, Matthias, et al.
Publicado: (2021)

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2017)

Programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Rohr‐Udilova, Nataliya, et al.
Publicado: (2021)

Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells
por: Wittmann, Philipp, et al.
Publicado: (2015)

Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?
por: Pinter, Matthias, et al.
Publicado: (2018)

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
por: Scheiner, Bernhard, et al.
Publicado: (2015)

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2018)

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation
por: Meischl, Tobias, et al.
Publicado: (2019)

EGFR has a tumor-promoting role in liver macrophages during hepatocellular carcinoma formation
por: Lanaya, Hanane, et al.
Publicado: (2014)

Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria
por: Pfisterer, Nikolaus, et al.
Publicado: (2020)

Transforming Growth Factor‐β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
por: Haider, Christine, et al.
Publicado: (2018)

Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding – A two decades experience
por: Bucsics, Theresa, et al.
Publicado: (2018)

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019)

The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes
por: Hartl, Lukas, et al.
Publicado: (2021)

Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients
por: Chromy, David, et al.
Publicado: (2017)

The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab
por: Li, Shuren, et al.
Publicado: (2017)

Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study
por: Scheiner, Bernhard, et al.
Publicado: (2016)

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study
por: Schöniger-Hekele, Maximilian, et al.
Publicado: (2009)

COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital
por: Pomej, Katharina, et al.
Publicado: (2021)

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
por: Scheiner, Bernhard, et al.
Publicado: (2022)

Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma
por: Samadaei, Mahzeiar, et al.
Publicado: (2022)

Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis
por: Paternostro, Rafael, et al.
Publicado: (2018)

Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure
por: Balcar, Lorenz, et al.
Publicado: (2021)

Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej, Katharina, et al.
Publicado: (2020)

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej, Katharina, et al.
Publicado: (2021)

Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma
por: Meischl, Tobias, et al.
Publicado: (2021)

Factors Affecting the Learning Curve in the Endoscopic Ultrasound-Guided Sampling of Solid Pancreatic Lesions: A Prospective Study
por: Razpotnik, Marcel, et al.
Publicado: (2023)

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2018)

Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mk28o5phlq66qk614r26vmapjt